Fund HoldingsSarissa Capital Management LP

Total Portfolio Value
$742.38M
Total Bought
$23.13M
Total Sold
$250.16M
Net Transaction
-$227.04M
Filing Period:
Securities
SharesValue ($K)
Q2 2023
Q3 2023
Change
Q2 2023
Q3 2023
Weight (%)
Change
NEUROCRINE BIOSCIENCES INC(NBIX)231,300366,000+134,70021,81241,1755.55%+19,363
AMARIN CORP PLC4,910,00010,442,453+5,532,4535,8439,6071.29%+3,764
INNOVIVA INC(INVA)7,277,0007,277,000092,63694,52812.73%+1,892
BIOCRYST PHARMACEUTICALS INC(BCRX)775,000775,00005,4565,4870.74%+31
REGULUS THERAPEUTICS INC185,183185,18302722540.03%-19
VOR BIOPHARMA INC(VOR)618,000618,00001,9101,3100.18%-599
GILEAD SCIENCES INC(GILD)920,400920,400070,93568,9759.29%-1,960
MERSANA THERAPEUTICS INC2,632,900550,000-2,082,9008,6626990.09%-7,964
IRONWOOD PHARMACEUTICALS INC16,390,00016,390,0000174,390157,83621.26%-16,554
BIOGEN INC(BIIB)643,000643,0000183,159165,25722.26%-17,901
ALKERMES PLC(ALKS)14,040,0007,042,200-6,997,800439,452197,25226.57%-242,200
Page 1 of 1